JP2000516938A - 牝馬の尿からエストロゲンを取得する方法 - Google Patents
牝馬の尿からエストロゲンを取得する方法Info
- Publication number
- JP2000516938A JP2000516938A JP10511195A JP51119598A JP2000516938A JP 2000516938 A JP2000516938 A JP 2000516938A JP 10511195 A JP10511195 A JP 10511195A JP 51119598 A JP51119598 A JP 51119598A JP 2000516938 A JP2000516938 A JP 2000516938A
- Authority
- JP
- Japan
- Prior art keywords
- urine
- water
- mixture
- volume
- adsorbent resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002700 urine Anatomy 0.000 title claims abstract description 47
- 229940011871 estrogen Drugs 0.000 title claims description 24
- 239000000262 estrogen Substances 0.000 title claims description 24
- 229920005989 resin Polymers 0.000 claims abstract description 56
- 239000011347 resin Substances 0.000 claims abstract description 56
- 229940035811 conjugated estrogen Drugs 0.000 claims abstract description 44
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 239000003463 adsorbent Substances 0.000 claims abstract description 42
- QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical compound [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 17
- 229920000642 polymer Polymers 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000003480 eluent Substances 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 11
- 150000002148 esters Chemical class 0.000 claims description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 10
- -1 aliphatic ketones Chemical class 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 238000001179 sorption measurement Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000002594 sorbent Substances 0.000 claims description 6
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 150000002170 ethers Chemical class 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 239000000284 extract Substances 0.000 abstract description 4
- 238000002414 normal-phase solid-phase extraction Methods 0.000 abstract description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 9
- 229930003836 cresol Natural products 0.000 description 9
- HVDGDHBAMCBBLR-UHFFFAOYSA-N enterolactone Chemical compound OC1=CC=CC(CC2C(C(=O)OC2)CC=2C=C(O)C=CC=2)=C1 HVDGDHBAMCBBLR-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229920001429 chelating resin Polymers 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical class OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000012465 retentate Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229920006112 polar polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BNHGVULTSGNVIX-UHFFFAOYSA-N 1-(2-ethoxyethoxy)ethanol Chemical compound CCOCCOC(C)O BNHGVULTSGNVIX-UHFFFAOYSA-N 0.000 description 1
- 206010003439 Artificial menopause Diseases 0.000 description 1
- HVDGDHBAMCBBLR-PBHICJAKSA-N Enterolactone Chemical compound OC1=CC=CC(C[C@H]2[C@@H](C(=O)OC2)CC=2C=C(O)C=CC=2)=C1 HVDGDHBAMCBBLR-PBHICJAKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Lubrication Of Internal Combustion Engines (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.妊娠した牝馬の尿から、フェノール性尿内容物の枯渇した、天然の共役エス トロゲン混合物を取得する方法において、 a)粘液状物および固形物を除去した尿、この尿の濃縮した濃縮物またはこの 尿の膜濾過により得られた濃縮した尿保持物質である尿液を、尿液中に含有され ている共役エストロゲン混合物の吸着のために十分な量の非イオン半極性ポリマ ーの吸着剤樹脂と接触させ、共役エストロゲン混合物を負荷した半極性ポリマー の吸着剤樹脂を残りの尿液から分離し、 b)共役エストロゲン混合物を負荷した非イオン半 極性ポリマーの吸着剤樹 脂を、少なくとも12.0のpH範囲に調節した洗浄水で洗浄し、および c)洗浄した吸着剤樹脂を、それに吸着された共役エストロゲンの混合物の脱 着のために十分な量の、水と混和可能のエーテル、低級アルカノールおよび低級 脂肪族ケトンの群からの水と混和可能の有機溶剤、または水と混和可能の有機溶 剤および場合によりアルカリ性に調節した水からなる混合物である溶離液と接触 させ、天然の共役エストロゲン混合物を含有する溶出液を吸着剤樹脂から分離し 、場合により濃縮することを特徴とする牝馬の尿からエストロゲンを取得する方 法。 2.工程a)において非イオン半極性の吸着剤樹脂としてマクロ多孔性のポリカ ルボン酸エステル樹脂を使用することを特徴とする請求項1記載の方法。 3.ポリカルボン酸エステル樹脂として、架橋脂肪族ポリカルボン酸エステル樹 脂、有利にはマクロ網状構造を有する架橋ポリアクリルエステル樹脂を使用する ことを特徴とする請求項2記載の方法。 4.工程a)において、非イオン半極性の吸着剤樹脂1容量部に、尿20〜80 容量部、とくに30〜50容量部に相当する量の尿液を負荷することを特徴とす る請求項1から3までのいずれか1項記載の方法。 5.工程a)において、尿液を毎時吸着剤樹脂1容量部あたり尿3〜10容量部 、とくに5〜7容量部の通過に相当する通過速度で、非イオン半極性ポリマーの 吸着剤樹脂を含有する反応器に通すことを特徴とする請求項1から4までのいず れか1項記載の方法。 6.工程b)において使用される洗浄水は、約pH12.5〜13.5に調節し た水酸化ナトリウム水溶液であることを特徴とする請求項1から5までのいずれ か1項記載の方法。 7.工程c)において、溶離液として水および水と混和可能の有機溶剤からなる 、20:80〜40:60、殊に30:70の範囲内の有機溶剤対水の容量 比を有する混合物を使用することを特徴とする請求項1から6までのいずれか1 項記載の方法。 8.工程c)において、エタノール含有溶離液を使用することを特徴とする請求 項1から7までのいずれか1項記載の方法。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1996/003820 WO1998008526A1 (de) | 1996-08-30 | 1996-08-30 | Verfahren zur gewinnung von oestrogenen aus stutenharn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000516938A true JP2000516938A (ja) | 2000-12-19 |
| JP4285773B2 JP4285773B2 (ja) | 2009-06-24 |
Family
ID=8166300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51119598A Expired - Fee Related JP4285773B2 (ja) | 1996-08-30 | 1996-08-30 | 牝馬の尿からエストロゲンを取得する方法 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0923381B1 (ja) |
| JP (1) | JP4285773B2 (ja) |
| AT (1) | ATE264109T1 (ja) |
| AU (1) | AU722739B2 (ja) |
| CA (1) | CA2263757C (ja) |
| CZ (1) | CZ298761B6 (ja) |
| DE (2) | DE59610985D1 (ja) |
| DK (1) | DK0923381T3 (ja) |
| ES (1) | ES2219694T3 (ja) |
| HU (1) | HU228763B1 (ja) |
| IL (1) | IL128670A (ja) |
| NO (1) | NO318390B1 (ja) |
| PL (1) | PL185919B1 (ja) |
| PT (1) | PT923381E (ja) |
| SK (1) | SK281368B6 (ja) |
| WO (1) | WO1998008526A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005513059A (ja) * | 2001-12-14 | 2005-05-12 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 複合エストロゲン天然混合物を調節して放出するマトリックス−被膜錠剤 |
| JP2005516923A (ja) * | 2001-12-14 | 2005-06-09 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結合型エストロゲン天然混合物を錠剤化するためのプレ調製物 |
| JP4778233B2 (ja) * | 2002-10-11 | 2011-09-21 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 非結合型の親油性化合物が少ない、結合型ウマエステロゲンの天然混合物の獲得方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10037389A1 (de) | 2000-08-01 | 2002-02-14 | Solvay Pharm Gmbh | Verfahren und Vorrichtung zur Anreicherung und Stabilisierung von konjugierten Oestrogenen aus Stutenharn |
| DE10159161A1 (de) | 2001-12-01 | 2003-06-18 | Solvay Pharm Gmbh | Verfahren zur Gewinnung von Oestrogenen aus Stutenharn |
| US20040072814A1 (en) | 2002-10-11 | 2004-04-15 | Solvay Pharmaceuticals Gmbh | Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| CN1332973C (zh) * | 2003-03-06 | 2007-08-22 | 深圳市海达克实业有限公司 | 结合态雌性激素的提取方法 |
| CN100422206C (zh) * | 2003-07-17 | 2008-10-01 | 索尔瓦药物有限公司 | 结合型马雌激素天然混合物的获取方法 |
| EP1675867A4 (en) * | 2003-10-24 | 2013-04-10 | Thorgard Pharmaceuticals Asut Pty Ltd | EXTRACTION OF ESTROGEN FROM URINE PREGNANT ANIMALS |
| US20140371180A1 (en) | 2013-06-14 | 2014-12-18 | Dr. Reddy's Laboratories Ltd. | Process for purification and isolation of estrogens |
| CN116371009A (zh) * | 2023-04-11 | 2023-07-04 | 山东畜牧兽医职业学院 | 一种马属动物妊娠期尿液雌激素分离机及分离方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7111863A (ja) * | 1970-10-13 | 1972-04-17 | ||
| CS224881B1 (cs) * | 1981-10-21 | 1984-01-16 | Jiri Semenka | Prostředek pro izolaci celkových 17-oxosteroiďú z biologického materiálu na bázi sorbentů |
-
1996
- 1996-08-30 DE DE59610985T patent/DE59610985D1/de not_active Expired - Lifetime
- 1996-08-30 HU HU9903776A patent/HU228763B1/hu not_active IP Right Cessation
- 1996-08-30 WO PCT/EP1996/003820 patent/WO1998008526A1/de not_active Ceased
- 1996-08-30 CZ CZ0059899A patent/CZ298761B6/cs not_active IP Right Cessation
- 1996-08-30 PL PL96331884A patent/PL185919B1/pl unknown
- 1996-08-30 DE DE19681621T patent/DE19681621D2/de not_active Expired - Fee Related
- 1996-08-30 ES ES96930139T patent/ES2219694T3/es not_active Expired - Lifetime
- 1996-08-30 SK SK245-99A patent/SK281368B6/sk not_active IP Right Cessation
- 1996-08-30 JP JP51119598A patent/JP4285773B2/ja not_active Expired - Fee Related
- 1996-08-30 AU AU69304/96A patent/AU722739B2/en not_active Ceased
- 1996-08-30 CA CA002263757A patent/CA2263757C/en not_active Expired - Fee Related
- 1996-08-30 PT PT96930139T patent/PT923381E/pt unknown
- 1996-08-30 IL IL12867096A patent/IL128670A/en not_active IP Right Cessation
- 1996-08-30 EP EP96930139A patent/EP0923381B1/de not_active Expired - Lifetime
- 1996-08-30 DK DK96930139T patent/DK0923381T3/da active
- 1996-08-30 AT AT96930139T patent/ATE264109T1/de active
-
1999
- 1999-02-26 NO NO19990952A patent/NO318390B1/no not_active IP Right Cessation
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005513059A (ja) * | 2001-12-14 | 2005-05-12 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 複合エストロゲン天然混合物を調節して放出するマトリックス−被膜錠剤 |
| JP2005516923A (ja) * | 2001-12-14 | 2005-06-09 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 結合型エストロゲン天然混合物を錠剤化するためのプレ調製物 |
| US8268351B2 (en) | 2001-12-14 | 2012-09-18 | Abbott Products Gmbh | Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
| JP4778233B2 (ja) * | 2002-10-11 | 2011-09-21 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 非結合型の親油性化合物が少ない、結合型ウマエステロゲンの天然混合物の獲得方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE264109T1 (de) | 2004-04-15 |
| CZ298761B6 (cs) | 2008-01-23 |
| DE19681621D2 (de) | 1999-09-30 |
| IL128670A0 (en) | 2000-01-31 |
| NO318390B1 (no) | 2005-03-14 |
| NO990952L (no) | 1999-02-26 |
| CA2263757C (en) | 2007-10-23 |
| NO990952D0 (no) | 1999-02-26 |
| EP0923381A1 (de) | 1999-06-23 |
| AU722739B2 (en) | 2000-08-10 |
| WO1998008526A1 (de) | 1998-03-05 |
| CZ59899A3 (cs) | 1999-06-16 |
| CA2263757A1 (en) | 1998-03-05 |
| DK0923381T3 (da) | 2004-05-10 |
| HK1021884A1 (en) | 2000-07-14 |
| DE59610985D1 (de) | 2004-05-19 |
| PL185919B1 (pl) | 2003-08-29 |
| HUP9903776A2 (hu) | 2000-03-28 |
| PL331884A1 (en) | 1999-08-16 |
| ES2219694T3 (es) | 2004-12-01 |
| EP0923381B1 (de) | 2004-04-14 |
| SK281368B6 (sk) | 2001-02-12 |
| PT923381E (pt) | 2004-09-30 |
| IL128670A (en) | 2001-05-20 |
| HUP9903776A3 (en) | 2000-04-28 |
| JP4285773B2 (ja) | 2009-06-24 |
| AU6930496A (en) | 1998-03-19 |
| HU228763B1 (hu) | 2013-05-28 |
| SK24599A3 (en) | 1999-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000516938A (ja) | 牝馬の尿からエストロゲンを取得する方法 | |
| US5723454A (en) | Method for obtaining estrogens from pregnant mare urine by solid phase extraction on a semi-polar adsorber resin | |
| JP4125788B2 (ja) | 牝馬の尿からエストロゲンを取得する方法 | |
| AU2002352161B2 (en) | Method for obtaining oestrogen from mare urine | |
| US8349819B2 (en) | Steroid extraction process from urine sources | |
| RU2179028C2 (ru) | Способ извлечения эстрогенов из мочи кобылы | |
| US6855704B2 (en) | Process for isolating conjugated estrogens | |
| JP4691028B2 (ja) | ウマ結合型エストロゲン天然混合物を得るための方法 | |
| CN1101682C (zh) | 由牝马尿液获取雌激素的方法 | |
| CN1101683C (zh) | 由牝马尿获取雌激素的方法 | |
| MXPA99001923A (es) | Procedimiento para la obtencion de estrogenos a partir de orina de yeguas | |
| HK1021884B (en) | Method to obtain oestrogens from mare's urine | |
| HK1023063B (en) | Process to obtain oestrogens from mare's urine | |
| HK1091841B (en) | Method for obtaining a natural mixture of conjugated equine estrogens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060815 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061115 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070105 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070215 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070515 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080819 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081117 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090115 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090311 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090324 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120403 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130403 Year of fee payment: 4 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130403 Year of fee payment: 4 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140403 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |